Two years ago, Martin Cusack, a businessman who had founded several start-ups in a variety of industries, chanced to be standing near the fax machine in a small medical clinic in South Florida. Faxes from researchers at well-known institutions like Johns Hopkins and the Mayo Clinic, as well as from multinational pharmaceutical companies, came in continually, says Cusack, although there wasn't that much activity in the clinic.
In the course of validating disease targets or developing drugs, researchers need tissue samples from patients with specific types of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?